These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 16160737

  • 1. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.
    Horwitz MJ, Tedesco MB, Sereika SM, Syed MA, Garcia-Ocaña A, Bisello A, Hollis BW, Rosen CJ, Wysolmerski JJ, Dann P, Gundberg C, Stewart AF.
    J Bone Miner Res; 2005 Oct; 20(10):1792-803. PubMed ID: 16160737
    [Abstract] [Full Text] [Related]

  • 2. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
    Horwitz MJ, Tedesco MB, Sereika SM, Hollis BW, Garcia-Ocaña A, Stewart AF.
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
    [Abstract] [Full Text] [Related]

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 4. A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover.
    Horwitz MJ, Tedesco MB, Sereika SM, Prebehala L, Gundberg CM, Hollis BW, Bisello A, Garcia-Ocaña A, Carneiro RM, Stewart AF.
    J Bone Miner Res; 2011 Sep; 26(9):2287-97. PubMed ID: 21544866
    [Abstract] [Full Text] [Related]

  • 5. Effect of parathyroid hormone on renal calbindin-D28k.
    Hemmingsen C, Staun M, Lewin E, Nielsen PK, Olgaard K.
    J Bone Miner Res; 1996 Aug; 11(8):1086-93. PubMed ID: 8854244
    [Abstract] [Full Text] [Related]

  • 6. Parathyroid hormone-related protein induced coupled increases in bone formation and resorption markers for 7 years in a patient with malignant islet cell tumors.
    Takeuchi Y, Fukumoto S, Nakayama K, Tamura Y, Yanagisawa A, Fujita T.
    J Bone Miner Res; 2002 May; 17(5):753-7. PubMed ID: 12009004
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
    Stewart AF, Cain RL, Burr DB, Jacob D, Turner CH, Hock JM.
    J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
    [Abstract] [Full Text] [Related]

  • 9. Vitamin D physiology.
    Lips P.
    Prog Biophys Mol Biol; 2006 Sep; 92(1):4-8. PubMed ID: 16563471
    [Abstract] [Full Text] [Related]

  • 10. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E, Azuma Y, Saito H, Tsunenari T, Watanabe T, Hirabayashi M, Sato K, Yamada-Okabe H, Ogata E.
    Clin Cancer Res; 2005 Jun 01; 11(11):4198-203. PubMed ID: 15930357
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Parathyroid hormone (PTH)-related protein(1-36) is equipotent to PTH(1-34) in humans.
    Everhart-Caye M, Inzucchi SE, Guinness-Henry J, Mitnick MA, Stewart AF.
    J Clin Endocrinol Metab; 1996 Jan 01; 81(1):199-208. PubMed ID: 8550752
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 1,25-dihydroxyvitamin D3 as well as its analogue OCT lower blood calcium through inhibition of bone resorption in hypercalcemic rats with continuous parathyroid hormone-related peptide infusion.
    Endo K, Katsumata K, Hirata M, Masaki T, Kubodera N, Nakamura T, Ikeda K, Ogata E.
    J Bone Miner Res; 2000 Jan 01; 15(1):175-81. PubMed ID: 10646127
    [Abstract] [Full Text] [Related]

  • 16. Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone.
    Goltzman D.
    Arch Biochem Biophys; 2008 May 15; 473(2):218-24. PubMed ID: 18358824
    [Abstract] [Full Text] [Related]

  • 17. In vivo administration of 1,25-dihydroxyvitamin D3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTH.
    Ueno Y, Shinki T, Nagai Y, Murayama H, Fujii K, Suda T.
    J Cell Biochem; 2003 Oct 01; 90(2):267-77. PubMed ID: 14505343
    [Abstract] [Full Text] [Related]

  • 18. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P.
    APMIS Suppl; 2001 Oct 01; (102):1-52. PubMed ID: 11419022
    [Abstract] [Full Text] [Related]

  • 19. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
    Haq M, Kremer R, Goltzman D, Rabbani SA.
    J Clin Invest; 1993 Jun 01; 91(6):2416-22. PubMed ID: 8514854
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.